There are many pharmacologic therapies that are being used or considered for treatment of
coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence …

Introduction The recovery of other pathogens in patients with SARS-CoV-2 infection has
been reported, either at the time of a SARS-CoV-2 infection diagnosis (co-infection) or …

Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

Importance Pulse oximetry guides triage and therapy decisions for COVID-19. Whether
reported racial inaccuracies in oxygen saturation measured by pulse oximetry are present in …

Background Frequent use of antibiotics in patients with COVID-19 threatens to exacerbate
antimicrobial resistance. We aimed to establish the prevalence and predictors of bacterial …

Background Evidence around prevalence of bacterial coinfection and pattern of antibiotic
use in COVID-19 is controversial although high prevalence rates of bacterial coinfection …

Background The prevalence of bacterial infection in patients with COVID-19 is low, however,
empiric antibiotic use is high. Risk stratification may be needed to minimize unnecessary …

The aims of this study were to analyze the utilization of antibiotics before (2018, 2019) and
during the COVID-19 pandemic (2020) and the practice of prescribing antibiotics in …

Background: COVID-19 patients are typically prescribed antibiotics empirically despite
concerns. There is a need to evaluate antibiotic use among hospitalized COVID-19 patients …

We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19).
Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide …